| Literature DB >> 16332055 |
Yujun Zheng1, Karanam Balasubramanyam, Marek Cebrat, Donald Buck, Fabien Guidez, Arthur Zelent, Rhoda M Alani, Philip A Cole.
Abstract
This paper describes the first potent and selective p300 histone acetyltransferase (HAT) inhibitor which is effective in live cells. This compound 7 is a coenzyme A analogue conjugated to a cell permeabilizing oligoArg peptide via disulfide linkage. This compound was shown to block cellular histone acetylation and transcription using a p300-sensitive reporter. It should thus be broadly useful for dissecting the role of p300 HAT activity in physiologic and disease states.Entities:
Year: 2005 PMID: 16332055 DOI: 10.1021/ja0558544
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419